Zu den Inhalten springen

Hauptnavigation:

Kontakt | English | Sitemap

| Home > Zentren > Zentrum für Innere Medizin > I. Medizinische Klinik und Poliklinik > Publikationen > 2002

Publikationen 2002

Baeres M, Wies I, Czaja AJ, Herkel J, Kanzler S, Cancado ELR, Porta G, Nishioka M, Daehnrich C, Schlumberger W, Galle PR, Lohse AW:
Antibodies to soluble liver antigen / liver pancreas (SLA/LP) in autoimmune hepatitis from different countries: Detection by standardized enzyme immunoassay and western blot.
Gut 2002; 51: 259-264
http://www.ncbi.nlm.nih.gov/sites/entrez/11866281

Bläker M, de Weerth A, Tometten M, Schulz M, Höppner W, Arlt D, Hoang-Vu C, Dralle H, Terpe H, Jonas L, von Schrenck T:
Expression of the cholecystokinin2-receptor in normal human thyroid gland and medullary thyroid carcinoma.
Eur J Endocrinol 2002; 146: 89-96
http://www.ncbi.nlm.nih.gov/sites/entrez/14759564

Block A., Milasinovic D., Müller J., Schäfer P., Schäfer H.J., Ameis D., Windler E., Greten H.
Amplified, muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
Anticancer Research 2002; 22: 3285-3292
http://www.ncbi.nlm.nih.gov/sites/entrez/12530077

Bröring DC, Topp S, Schaefer U, Fischer L, Gundlach M, Sterneck M, Schoder V, Pothmann W, Rogiers X.:
Split liver transplantation and risk to the adult recipient: analysis using matched pairs
Journal of the American College of Surgeons 2002; 195(5): 648-657
http://www.ncbi.nlm.nih.gov/sites/entrez/12437252

Czaja AJ, Donaldson PT, Lohse AW:
Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
Am J Gastroenterol 2002; 97: 413-419
http://www.ncbi.nlm.nih.gov/sites/entrez/11866281

Dandri M, Burda MR, Buerkle A, Zuckerman DM, Will H, Greten H, Rogler CE, Petersen J.
Increase in de-novo hepatitis B virus DNA integrations in response to oxidative DNA damage or inhibition of poly (ADP-ribosyl)ation.
Hepatology 2002; 35: 217-223
http://www.ncbi.nlm.nih.gov/sites/entrez/11786979

Denzer U, Helmreich-Becker I, Galle PR, Lohse AW:
Minilaparoscopically-guided spleen biopsy in systemic disease with splenomegaly of unknown origin.
Endoscopy 2002; 34: 495-498
http://www.ncbi.nlm.nih.gov/sites/entrez/12048636

Fischer L, Sterneck M, Meier D, Zollner B, Rogiers X.:
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation
Transplantion Proceedings 2002; 34(6): 2283-2284
http://www.ncbi.nlm.nih.gov/sites/entrez/12270400

Herkel J, Heidrich B, Nieraad N, Wies I, Rother M, Lohse AW:
Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas: evidence against molecular mimicry and for a self antigen-driven immune reaction.
Hepatology 2002; 35: 404-408
http://www.ncbi.nlm.nih.gov/sites/entrez/11826415

Herkel J, Modrow JP, Bamberger S, Kanzler S, Rotter V, Cohen IR, Lohse AW.
Prevalence of autoantibodies to the p53 protein in autoimmune hepatitis.
Autoimmunity 2002; 35: 493-496
http://www.ncbi.nlm.nih.gov/sites/entrez/12765474

Mueller L, Broering DC, Meyer J, VashistY, Goettsche J, Wilms C and Rogiers X:
The induction of the immediate-early-genes EGR-1, PAI-1 and PRL-1 during liver regeneration in surgical models is related to increased portal flow.
J Hepatol 2002; 37: 606-612
http://www.ncbi.nlm.nih.gov/sites/entrez/12399226

Nickel R, Egle UT, Wunsch A, Lohse AW, Otto G:
Krankheitsbewältigung bei Patienten nach Lebertransplantation unter Berücksichtigung der Zugehörigkeit zu einer Selbsthilfegruppe.
Z Gastroenterol 2002; 40: 285-290
http://www.ncbi.nlm.nih.gov/sites/entrez/12016562

Nickel R, Wunsch A, Egle UT, Lohse AW, Otto G:
The relevance of anxiety, depression, and coping in patients after liver transplantation.
Liver Transpl 2002; 8: 63-71
http://www.ncbi.nlm.nih.gov/sites/entrez/11799488

Schlaak JF, Schramm C, Radecke K, zum Buschenfelde KH, Gerken G:
Sustained suppression of HCV replication and inflammatory activity after interleukin-2 therapy in patients with HIV/hepatitis C virus coinfection.
J Acquir Immune Defic Syndr 2002; 292:145-8
http://www.ncbi.nlm.nih.gov/sites/entrez/11832683

Schroter M, Laufs R, Sterneck M, Fischer L, Knodler B, Schafer P, Zöllner B, Feucht HH.:
SENV-H viremia and liver transplantation: significant increase of the prevalence
Blood 2002; 100(4): 1518-1519
http://www.ncbi.nlm.nih.gov/sites/entrez/12184282

Schroter M, Laufs R, Zollner B, Knodler B, Schäfer P, Sterneck M, Fischer L, Feucht HH.:
Prevalence of SENV-H viraemia among healthy subjects and individuals a for parenterally transmitted diseases in germany
Journal of Viral Hepatitis 2002; 9(6): 455-459
http://www.ncbi.nlm.nih.gov/sites/entrez/12431209

Sterneck M, Zadeh KM, Grotelüschen R, Bröring DC, Rogiers X.:
Clinical use of C2 monitoring in long-term liver transplant recipients
Transplantion Proceedings 2002; 34(8): 3304-3306
http://www.ncbi.nlm.nih.gov/sites/entrez/12493454

Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH:
Subtype dependent response of Hepatitis B Virus during the early phase of Lamivudine treatment.
Clin Inf Dis 2002; 34: 1273-7
http://www.ncbi.nlm.nih.gov/sites/entrez/11941556

Seitenanfang    Seite drucken


© Universitätsklinikum Hamburg-Eppendorf, Impressum, Datenschutzerklärung
Letzte Änderung: , 16.04.2008